NIH-funded research NIH-funded research

Understanding how the body’s immune signals may influence depression (TLR4 pathway)

Official title: In vivo inflammatory challenge to elucidate the role of the toll-like receptor 4 pathway in depression

Funded at Laureate Institute for Brain Research · NIH-11418993 · Data updated 2026-11-12

Researchers are testing how the immune system’s TLR4 pathway might contribute to depression by comparing responses to a controlled immune challenge in people with depression versus healthy individuals.

More Depression research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLaureate Institute for Brain Research
NIH-funded
Lab location1 site (Tulsa, United States)
Project startApril 1, 2022
Project endApril 30, 2027
Funding year2026
Award (this year)$242,753
NIH project number5R00MH126950-05
Project IDNIH-11418993 on NIH RePORTER

Who could benefit from this research

Could help

Adults with major depressive disorder or healthy controls willing to undergo a safe immune challenge and comply with study procedures.

Less likely to help

People who cannot safely receive an endotoxin challenge or who do not fit the study criteria may not benefit.

What this research studies

In this study, participants with major depressive disorder and healthy controls will receive a brief, controlled endotoxin (LPS) challenge or saline in a tightly monitored setting. The researchers will examine changes in inflammatory signals, brain activity, and regulatory molecules like miRNAs to see how TLR4 signaling differs between groups. The goal is to identify specific immune pathways that are altered in depression and could become targets for new treatments. The study uses blood and brain measurements to map the link between immune responses and depressive symptoms over a short time frame.

Why it matters

Potential benefit: If successful, findings could guide development of therapies that modulate immune pathways to relieve depressive symptoms.

How similar studies have gone: Prior endotoxemia studies show temporary mood and immune changes, supporting further exploration of this approach.

Where this research is happening

  • Laureate Institute for Brain Research
    Tulsa, United States
    Active

Researchers

  • Principal investigator: Figueroa-Hall, Leandra Kali — Laureate Institute for Brain Research
  • Study coordinator: Figueroa-Hall, Leandra Kali

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.